Media coverage
1
Media coverage
Title Rituximab Biosimilars Versus Originator: Comparing Long-Term Survival Benefit in DLBCL Degree of recognition International Media name/outlet ASH Clinical News Media type Web Date 01/10/2021 URL https://www.ashclinicalnews.org/news/from-the-blood-journals/blood-advances/rituximab-biosimilars-versus-originator-comparing-long-term-survival-benefit-dlbcl/ Persons Marcel Nijland